ArticleJournal of molecular neuroscience : MN2026
Environmental enrichment applied during epileptogenesis increases seizure latency and reduces serum interleukin-6 in a PTZ kindling model.
Article in Journal of molecular neuroscience : MN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epilepsy is a chronic neurological disorder affecting millions of individuals worldwide and is strongly associated with inflammatory processes. Although pharmacological treatment remains the first-line approach, approximately one-third of patients are refractory to available therapies. Environmental enrichment (EE) has been shown to improve cognitive function, reduce stress, and enhance neuroplasticity, suggesting its potential as a non-pharmacological strategy for neurological disorders.In this study, we investigated the effects of EE in a pentylenetetrazole (PTZ)-induced seizure model using different exposure paradigms. Animals were exposed either to EE for 30 days prior to seizure induction or during the 14-day PTZ kindling protocol. Seizure severity and latency were assessed, along with inflammatory (interleukin-6) and stress-related (cortisol) biomarkers.EE exposure during seizure induction significantly increased the latency to seizure onset compared to both the control and pre-exposed groups, with a significant Group × Session interaction across the kindling protocol and pronounced effects at later PTZ sessions. A borderline trend toward reduced seizure severity was also observed in this group, but day-specific differences did not survive correction for multiple comparisons. The EED group also exhibited significantly lower serum IL-6 levels compared with controls. No significant differences in cortisol levels were observed in serum or in the frontal cortex. Pre-exposure to EE did not produce significant protective effects on any of the outcomes evaluated.These findings suggest that EE exerts beneficial effects when applied during epileptogenic processes, particularly on the temporal progression of seizure susceptibility, and may be associated with changes in selected inflammatory markers. EE may represent a promising adjunct therapeutic strategy for epilepsy, although mechanistic studies with broader molecular characterization are still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.